-
Wed04Feb2026Fri06Feb2026
-
Fri20Feb2026Sat21Feb2026
-
Mon23Feb2026Fri27Feb2026
-
Thu05Mar2026Sat07Mar2026
-
Thu05Mar2026Sat07Mar2026
-
Wed11Mar2026Fri13Mar2026
-
Thu19Mar2026Sat21Mar2026
-
Thu26Mar2026Sat28Mar2026
Latest News
Positive loberamisal data underscore potential role for multi-target neuroprotective agents in...
Stroke patients who intravenously received the novel neuroprotective medication loberamisal (NeuroDawn Pharmaceutical) on a daily basis—for 10 days and starting within 48 hours of...
Features
NeuroNews’ top 10 most popular stories of December 2025
Several highlights from the Society of Vascular and Interventional Neurology (SVIN) annual meeting (19–22 November 2025, Orlando, USA) feature on NeuroNews’ final top 10...
NeuroNews’ top 10 most popular stories of November 2025
Multiple breakthroughs in mechanical thrombectomy treatments—from robotic systems and modality choices to large-core strokes—feature among NeuroNews’ most popular stories from last month. November also...
Videos
If the neurointerventional space is going to reduce its existing microplastics burden, “small, intuitive changes” made by physicians and companies alike may be an important initial step in the right direction. This is among the major messages Sophia Hohenstatt...

















